Published in J Cereb Blood Flow Metab on January 01, 1998
Inflammatory cytokines in experimental and human stroke. J Cereb Blood Flow Metab (2012) 2.25
Differential acute and chronic responses of tumor necrosis factor-deficient mice to experimental brain injury. Proc Natl Acad Sci U S A (1999) 1.91
Retracted Secretory phospholipase A2 IIA is up-regulated by TNF-alpha and IL-1alpha/beta after transient focal cerebral ischemia in rat. Brain Res (2007) 1.75
Tissue plasminogen activator (tPA) and matrix metalloproteinases in the pathogenesis of stroke: therapeutic strategies. CNS Neurol Disord Drug Targets (2008) 1.24
Focal cerebral ischemia in the TNFalpha-transgenic rat. J Neuroinflammation (2008) 1.04
Targeting neutrophils in ischemic stroke: translational insights from experimental studies. J Cereb Blood Flow Metab (2015) 1.03
Rational modulation of the innate immune system for neuroprotection in ischemic stroke. Front Neurosci (2015) 1.02
Cytokines: their role in stroke and potential use as biomarkers and therapeutic targets. Aging Dis (2014) 0.93
Targeting microglial activation in stroke therapy: pharmacological tools and gender effects. Curr Med Chem (2014) 0.93
Apoptotic death of neurons exhibiting peripherin aggregates is mediated by the proinflammatory cytokine tumor necrosis factor-alpha. J Cell Biol (2001) 0.92
Integration of cytokine biology and lipid metabolism in stroke. Front Biosci (2008) 0.92
Loss of NF-kappaB activity during cerebral ischemia and TNF cytotoxicity. Mol Med (1999) 0.91
Post-traumatic hypoxia exacerbates neurological deficit, neuroinflammation and cerebral metabolism in rats with diffuse traumatic brain injury. J Neuroinflammation (2011) 0.91
Anti-inflammatory effects of PJ34, a poly(ADP-ribose) polymerase inhibitor, in transient focal cerebral ischemia in mice. Br J Pharmacol (2006) 0.91
Opioid receptor activation: suppression of ischemia/reperfusion-induced production of TNF-α in the retina. Invest Ophthalmol Vis Sci (2011) 0.90
NNZ-2566 treatment inhibits neuroinflammation and pro-inflammatory cytokine expression induced by experimental penetrating ballistic-like brain injury in rats. J Neuroinflammation (2009) 0.87
Genetic ablation of soluble tumor necrosis factor with preservation of membrane tumor necrosis factor is associated with neuroprotection after focal cerebral ischemia. J Cereb Blood Flow Metab (2015) 0.84
Help-me signaling: Non-cell autonomous mechanisms of neuroprotection and neurorecovery. Prog Neurobiol (2016) 0.83
Neuroinflammation and cerebrovascular disease in old age: a translational medicine perspective. J Aging Res (2011) 0.83
Neutralizing anti-interleukin-1β antibodies modulate fetal blood-brain barrier function after ischemia. Neurobiol Dis (2014) 0.82
Mechanisms of tumor necrosis factor alpha action on neurodegeneration: interaction with insulin-like growth factor-1. Proc Natl Acad Sci U S A (1999) 0.82
Regional TNFα mapping in the brain reveals the striatum as a neuroinflammatory target after ventricular fibrillation cardiac arrest in rats. Resuscitation (2014) 0.81
Ulinastatin attenuates oxidation, inflammation and neural apoptosis in the cerebral cortex of adult rats with ventricular fibrillation after cardiopulmonary resuscitation. Clinics (Sao Paulo) (2013) 0.78
A Systematic, Integrated Study on the Neuroprotective Effects of Hydroxysafflor Yellow A Revealed by (1)H NMR-Based Metabonomics and the NF-κB Pathway. Evid Based Complement Alternat Med (2013) 0.78
Anti-IL-6 neutralizing antibody modulates blood-brain barrier function in the ovine fetus. FASEB J (2015) 0.78
Neuroinflammation and neuroimmune dysregulation after acute hypoxic-ischemic injury of developing brain. Front Pediatr (2015) 0.77
Evaluation of early macrophage activation and NF-kappaB activity in pulmonary injury caused by deep hypothermia circulatory arrest: an experimental study. Pediatr Cardiol (2009) 0.77
Therapeutic antibodies in stroke. Transl Stroke Res (2013) 0.77
Pathogenic mechanisms following ischemic stroke. Neurol Sci (2017) 0.76
Neutralizing anti-interleukin-1β antibodies reduce ischemia-related interleukin-1β transport across the blood-brain barrier in fetal sheep. Neuroscience (2017) 0.75
Effects of xuelian injection on cerebral TNF-α, IL-1β and MMP-9 in rats experienced focal cerebral ischemia/reperfusion. Int J Clin Exp Med (2014) 0.75
TNFα in cerebral ischemia: another stroke against you? J Neurochem (2015) 0.75
Carthamus tinctorius L. ameliorates brain injury followed by cerebral ischemia-reperfusion in rats by antioxidative and anti-inflammatory mechanisms. Iran J Basic Med Sci (2016) 0.75
The TNFα-Transgenic Rat: Hippocampal Synaptic Integrity, Cognition, Function, and Post-Ischemic Cell Loss. PLoS One (2016) 0.75
Systemic infusions of anti-interleukin-1β neutralizing antibodies reduce short-term brain injury after cerebral ischemia in the ovine fetus. Brain Behav Immun (2017) 0.75
Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest (2000) 5.07
Lymphocytes bearing antigen-specific gamma delta T-cell receptors accumulate in human infectious disease lesions. Nature (1989) 4.61
Virus-induced neuronal apoptosis blocked by the herpes simplex virus latency-associated transcript. Science (2000) 3.51
Tissue plasminogen activator (tPA) deficiency exacerbates cerebrovascular fibrin deposition and brain injury in a murine stroke model: studies in tPA-deficient mice and wild-type mice on a matched genetic background. Arterioscler Thromb Vasc Biol (1999) 2.56
In situ demonstration of T lymphocyte subsets in granulomatous inflammation: leprosy, rhinoscleroma and sarcoidosis. Clin Exp Immunol (1983) 2.21
Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice. Proc Natl Acad Sci U S A (1992) 2.16
T lymphocyte subsets in the skin lesions of patients with leprosy. J Am Acad Dermatol (1983) 2.01
Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease. CNS Neurol Disord Drug Targets (2009) 1.94
Preferential susceptibility of brain tumors to the antiangiogenic effects of an alpha(v) integrin antagonist. Neurosurgery (2001) 1.90
Immunoregulatory molecules and IL 2 receptors identified in multiple sclerosis brain. J Immunol (1986) 1.87
In situ identification of cells in human leprosy granulomas with monoclonal antibodies to interleukin 2 and its receptor. J Immunol (1984) 1.74
Anti-inflammatory, antithrombotic, and neuroprotective effects of activated protein C in a murine model of focal ischemic stroke. Circulation (2001) 1.67
Clearance of amyloid beta-peptide from brain: transport or metabolism? Nat Med (2000) 1.53
Human blood-brain barrier receptors for Alzheimer's amyloid-beta 1- 40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer. J Clin Invest (1998) 1.51
Absence of a prominent Th2 cytokine response in human tuberculosis. Infect Immun (1996) 1.51
The role of the cell surface LRP and soluble LRP in blood-brain barrier Abeta clearance in Alzheimer's disease. Curr Pharm Des (2008) 1.36
Isoform-specific effects of apolipoproteins E2, E3, and E4 on cerebral capillary sequestration and blood-brain barrier transport of circulating Alzheimer's amyloid beta. J Neurochem (1997) 1.35
Cerebrovascular accumulation and increased blood-brain barrier permeability to circulating Alzheimer's amyloid beta peptide in aged squirrel monkey with cerebral amyloid angiopathy. J Neurochem (1998) 1.34
Up-regulation of the cAMP/PKA pathway inhibits proliferation, induces differentiation, and leads to apoptosis in malignant gliomas. Lab Invest (1998) 1.26
Blood-brain barrier uptake of the 40 and 42 amino acid sequences of circulating Alzheimer's amyloid beta in guinea pigs. Neurosci Lett (1996) 1.17
Evidence for a lactate transport system in the sarcolemmal membrane of the perfused rabbit heart: kinetics of unidirectional influx, carrier specificity and effects of glucagon. Biochim Biophys Acta (1985) 1.17
Substitution at codon 22 reduces clearance of Alzheimer's amyloid-beta peptide from the cerebrospinal fluid and prevents its transport from the central nervous system into blood. Neurobiol Aging (2002) 1.16
Superoxide prevents nitric oxide-mediated suppression of helper T lymphocytes: decreased autoimmune encephalomyelitis in nicotinamide adenine dinucleotide phosphate oxidase knockout mice. J Immunol (2000) 1.10
Tumor necrosis factor expression during mouse hepatitis virus-induced demyelinating encephalomyelitis. J Virol (1995) 1.10
Chronic nicotine treatment enhances focal ischemic brain injury and depletes free pool of brain microvascular tissue plasminogen activator in rats. J Cereb Blood Flow Metab (1997) 1.08
Early activation of splenic macrophages by tumor necrosis factor alpha is important in determining the outcome of experimental histoplasmosis in mice. Infect Immun (1992) 1.08
Increased expression of tumor necrosis factor-alpha receptors in the brains of patients with AIDS. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.06
Mononuclear lymphoid populations infiltrating the microenvironment of primary CNS tumors. Characterization of cell subsets with monoclonal antibodies. J Neurosurg (1984) 1.05
Blood-brain barrier permeability to leucine-enkephalin, D-alanine2-D-leucine5-enkephalin and their N-terminal amino acid (tyrosine). Brain Res (1985) 1.04
Effects of tumor necrosis factor-alpha and interleukin-6 on fluid-phase permeability and ammonia diffusion in CNS-derived endothelial cells. J Investig Med (1996) 1.02
T-lymphocyte subsets in lymph nodes from homosexual men. JAMA (1983) 1.01
B- and T-lymphocytes in Hodgkin's disease. An immunohistochemical study utilizing heterologous and monoclonal antibodies. Cancer (1985) 1.00
Glycoprotein 330/megalin (LRP-2) has low prevalence as mRNA and protein in brain microvessels and choroid plexus. Exp Neurol (1999) 0.99
Extensive peroxynitrite activity during progressive stages of central nervous system inflammation. J Neuroimmunol (1997) 0.98
Altered distribution of B and T lymphocytes in lymph-nodes from homosexual men with Kaposi's sarcoma. Lancet (1983) 0.98
Analysis of B-cell antigens in normal reactive lymphoid tissue using four B-cell monoclonal antibodies. Blood (1983) 0.98
Cytoplasmic as opposed to surface Ia antigens expressed on human peripheral blood lymphocytes and monocytes. Clin Exp Immunol (1982) 0.95
Regional distribution of thrombomodulin in human brain. Brain Res (1991) 0.94
Heterogeneity of macrophage populations in human lymphoid tissue and peripheral blood. Cell Immunol (1984) 0.93
The role of neutralizing antibody and T-helper subtypes in protection and pathogenesis of vaccinated mice following ocular HSV-1 challenge. Immunology (1998) 0.92
Detection of brain tumor invasion and micrometastasis in vivo by expression of enhanced green fluorescent protein. Neurosurgery (1998) 0.92
Demonstration in situ of subsets of T-lymphocytes in sarcoidosis. Am J Dermatopathol (1984) 0.91
Kinetics and Na independence of amino acid uptake by blood side of perfused sheep choroid plexus. Am J Physiol (1990) 0.90
Endothelin-1 and monocyte chemoattractant protein-1 modulation in ischemia and human brain-derived endothelial cell cultures. J Neuroimmunol (2001) 0.89
Class II antigen expression by lacrimal epithelial cells. An updated working hypothesis for antigen presentation by epithelial cells. Invest Ophthalmol Vis Sci (1991) 0.89
Kaposi's sarcoma in homosexual men: an immunohistochemical study. J Am Acad Dermatol (1983) 0.87
Primary central nervous system lymphoma in homosexual men. Clinical, immunologic, and pathologic features. Am J Med (1985) 0.87
Immunoperoxidase techniques applied to dermatopathology. J Cutan Pathol (1983) 0.87
Cytokine expression in radiation-induced delayed cerebral injury. Neurosurgery (1994) 0.86
Nicotine increases plasminogen activator inhibitor-1 production by human brain endothelial cells via protein kinase C-associated pathway. Stroke (1999) 0.86
In situ identification of activated Ta1+ T lymphocytes in human leprosy skin lesions. Int J Lepr Other Mycobact Dis (1987) 0.86
Recombination between feline exogenous and endogenous retroviral sequences generates tropism for cerebral endothelial cells. Am J Pathol (1994) 0.84
In situ localization of T lymphocytes in disseminated coccidioidomycosis. J Infect Dis (1985) 0.84
Molecular characterization of a reduced glutathione transporter in the lens. Invest Ophthalmol Vis Sci (1995) 0.84
Specific and nonspecific immune stimulation of MHC-II-deficient mice results in chronic HSV-1 infection of the trigeminal ganglia following ocular challenge. Virology (1999) 0.84
The effects of (R) alpha-methyl histamine on the isolated guinea pig aorta. Agents Actions Suppl (1991) 0.83
Brain capillary tissue plasminogen activator in a diabetes stroke model. Stroke (1996) 0.83
In situ characterization of T lymphocyte subsets in leprosy granulomas. Int J Lepr Other Mycobact Dis (1982) 0.83
Ontogeny of B cell markers in the human fetal liver. J Immunol (1984) 0.83
Pathogenicity of a subgroup C feline leukemia virus (FeLV) is augmented when administered in association with certain FeLV recombinants. Virology (1994) 0.82
Cytokines and immunoregulatory molecules in malignant glial neoplasms. J Neurosurg (1992) 0.82
Soluble TNF-alpha receptors are constitutively shed and downregulate adhesion molecule expression in malignant gliomas. J Neuropathol Exp Neurol (1997) 0.82
Influence of the 3K3A-activated protein C variant on the plasma clot lysis activity of t-PA and of t-PA on the variant's anticoagulant activity. J Thromb Haemost (2013) 0.81
Distribution of cells bearing the Tac antigen during ontogeny of human lymphoid tissue. J Immunol (1985) 0.81
Exogenous microglia enter the brain and migrate into ischaemic hippocampal lesions. Neurosci Lett (1999) 0.81
Vaccination with different HSV-1 glycoproteins induces different patterns of ocular cytokine responses following HSV-1 challenge of vaccinated mice. Vaccine (1999) 0.81
T cell chronic lymphocytic leukaemia with suppressor phenotype. Clin Exp Immunol (1982) 0.81
Cereport (RMP-7) increases the permeability of human brain microvascular endothelial cell monolayers. Pharm Res (1999) 0.81
Identification of a novel, sodium-dependent, reduced glutathione transporter in the rat lens epithelium. Invest Ophthalmol Vis Sci (1996) 0.80
Corneal transport of circulating glutathione in normal and galactosemic guinea pigs. Cornea (1999) 0.80
Nicotine downregulates alpha 2 isoform of Na,K-ATPase at the blood-brain barrier and brain in rats. Biochem Biophys Res Commun (1994) 0.80
Intravenous RMP-7 increases delivery of ganciclovir into rat brain tumors and enhances the effects of herpes simplex virus thymidine kinase gene therapy. Hum Gene Ther (1998) 0.80
Strategies to circumvent vascular barriers of the central nervous system. Neurosurgery (1998) 0.80
Attenuation of brain injury and reduction of neuron-specific enolase by nicardipine in systemic circulation following focal ischemia and reperfusion in a rat model. J Neurosurg (1997) 0.79
Blood-brain barrier permeability to dipeptides and their constituent amino acids. Brain Res (1983) 0.79
Differential CD3/T cell antigen receptor-mediated IL-2 production in jurkat T cells. Dissociation of IL-2 response from total inositol phosphate and calcium responses. J Immunol (1990) 0.79
Antigen presentation to Th1 but not Th2 cells by macrophages results in nitric oxide production and inhibition of T cell proliferation: interferon-gamma is essential but insufficient. Cell Immunol (2000) 0.79
Induction of intercellular adhesion molecule-1 by tumor necrosis factor-alpha through the 55-kDa receptor is dependent on protein kinase C in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci (1996) 0.79
Liver and lens glutathione and cysteine regulation in galactose-fed guinea pigs. Curr Eye Res (1997) 0.79
Electroencephalographic characteristics of audiogenic seizures induced in metaphit-treated small rodents. Epilepsia (1992) 0.78
Cell cycle phase-specific survival of CD95 ligand-challenged Jurkat cells: upregulation of heat-shock response. Cell Immunol (2001) 0.78
Stability of T- and B-cell numbers in human peripheral blood. Am J Clin Pathol (1982) 0.78
Differential effects of tumor necrosis factor-alpha on proliferation, cell surface antigen expression, and cytokine interactions in malignant gliomas. Neurosurgery (1993) 0.78
Immunohistochemical localization of tissue plasminogen activator in vascular endothelium of stroke-prone regions of the rat brain. Neurosurgery (1998) 0.78
Thrombomodulin expression in bovine brain capillaries. Anticoagulant function of the blood-brain barrier, regional differences, and regulatory mechanisms. Arterioscler Thromb Vasc Biol (1997) 0.78
TGF-B2 and soluble p55 TNFR modulate VCAM-1 expression in glioma cells and brain derived endothelial cells. J Neuroimmunol (1997) 0.78
Endothelin-1-induced interleukin-8 production in human brain-derived endothelial cells is mediated by the protein kinase C and protein tyrosine kinase pathways. Blood (1999) 0.78
Metaphit, an isothiocyanate analog of PCP, induces audiogenic seizures in mice. Eur J Pharmacol (1989) 0.77
Endothelin-1 enhances plasminogen activator inhibitor-1 production by human brain endothelial cells via protein kinase C-dependent pathway. Arterioscler Thromb Vasc Biol (1999) 0.77
Effects of sensory-motor cortical lesions on blood-brain permeability in guinea pigs. Metab Brain Dis (1989) 0.77
Chronic amphetamine intoxication and the blood-brain barrier permeability to inert polar molecules studied in the vascularly perfused guinea pig brain. J Neurol Sci (1989) 0.77
A simple technique to determine glutathione (GSH) levels and synthesis in ocular tissues as GSH-bimane adduct: application to normal and galactosemic guinea-pigs. Exp Eye Res (1993) 0.77
RMP-7, a bradykinin agonist, increases permeability of blood-ocular barriers in the guinea pig. Invest Ophthalmol Vis Sci (1995) 0.77
Soluble tumor necrosis factor receptors are present in human vitreous and shed by retinal pigment epithelial cells. Exp Eye Res (1996) 0.77
Enhancement of spontaneous killer cytotoxicity by soluble factor. Clin Exp Immunol (1980) 0.77
Galactose-induced cataract formation in guinea pigs: morphologic changes and accumulation of galactitol. Invest Ophthalmol Vis Sci (1994) 0.77
Intravenous infusion of RMP-7 increases ocular uptake of ganciclovir. Pharm Res (1997) 0.77